HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 3.25
Day range
kr 3.20 - kr 3.36
Year range
kr 3.20 - kr 8.43
Market cap
155.80M SEK
Avg Volume
167.60K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.12M | -38.26% |
Net income | -5.06M | 36.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.86M | -60.87% |
Total assets | 20.90M | -54.94% |
Total liabilities | 2.60M | -80.93% |
Total equity | 18.30M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -52.94% | — |
Return on capital | -61.41% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2026info | Y/Y change |
|---|---|---|
Net income | -5.06M | 36.86% |
Cash from operations | -6.98M | -837.33% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -6.98M | -136.27% |
Free cash flow | -5.12M | -330.25% |
About
Founded
2014
Website
Employees
2
